← Eichor
Study identifier: NCT06794047 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effect of VitC on IVF Outcome of DOR Patients

Condition: Diminished Ovarian Reserve · IVF Outcomes  ·  Sponsor: Peking University Third Hospital

PhaseNA
Planned participants1100
Who can joinFemale, 20 Years to 45 Years
Healthy volunteersNo

About this study

In the context of the accelerating aging population and the continuous decline in birth rates nationwide, delaying reproductive aging in women and protecting the fertility of women of childbearing age have become urgent issues and key demands that need to be addressed in the field of maternal and child health in China. The ovaries have reproductive and hormone secretion functions and are crucial throughout the female reproductive lifecycle. Women of childbearing age in China face a serious problem of diminished ovarian reserve (DOR), which can lead to infertility, failed in vitro fertilization (IVF) treatments, miscarriage, and other adverse pregnancy outcomes, severely affecting the safety of women and their offspring. For DOR patients who desire to conceive, failure to intervene and treat promptly can result in irreversible losses and impose a significant psychological burden on them. However, there are currently no clear and reliable interventions that can improve ovarian function and enhance fertility in women with DOR. Therefore, exploring new, safe, and patient-acceptable intervention strategies is urgently needed, as it may bring hope and light to women with DOR. Nutrient supplementation, especially vitamin supplementation, has received increasing attention in disease treatment due to its safety, bioavailability, and effectiveness. Previous studies have shown that vitamin C may play an important role in treating diminished ovarian reserve. However, its effects on ovari…

This description comes directly from the study's public registry record.

Talk to the study team

Tian Tian, Ph.D  ·  +86 01082266355  ·  tiantianpku@126.com

Always discuss trial participation with your own doctor first.

Locations (6)

Beijing Obstetrics and Gynecology Hospital,Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting
Peking university third hospitalBeijing, Beijing Municipality, ChinaRecruiting
The second hospital of Hebei Medical UniversityShijiazhuang, Hebei, ChinaRecruiting
General Hospital of Ningxia Medical UniversityYinchuan, Ningxia, ChinaRecruiting
Tang Du HospitalXi’an, Shanxi, ChinaRecruiting
Peking University Shenzhen HospitalShenzhen, Shenzhen, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06794047